Obtain IC50 values for compound-induced cytotoxicity within a 120-cell line panel that would assist US in determining what cancer has inherent vulnerabilities to OTS964.
Ended Purchase Order Awarded
- Contract number
- 75N95020P00078
- Awardee
-
Reaction Biology Corporation UEI LDBCLKM4WJH1
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,500
Award facts
- Opportunity
-
- 75N95020Q00031 Solicitation number
- Contract value 100% obligated
- $14,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Malvern, PA 19355, USA
Award details come from SAM.gov/FPDS.
About this award
This contract was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Reaction Biology Corporation, a small disadvantaged business. The $14,500 firm fixed-price purchase order requires Reaction Biology to obtain IC50 values (half-maximal inhibitory concentration) for compound-induced cytotoxicity within a 120-cell line panel. This would assist NCATS in determining what cancers have inherent vulnerabilities to the compound OTS964. The contract does not have a small business set-aside designation. Reaction Biology is a drug discovery contract research organization that specializes in preclinical services like enzyme activity assays and cytotoxicity screening to support biomedical research initiatives across NIH institutes.
Quick answers
Who was awarded contract 75N95020P00078?
75N95020P00078 was awarded to Reaction Biology Corporation by National Institute on Drug Abuse (National Institutes of Health) on January 28, 2020.
How much is contract 75N95020P00078 worth?
The government has obligated $14,500 on 75N95020P00078.
Which agency awarded contract 75N95020P00078?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00078, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95020P00078 competed?
The extent of competition for 75N95020P00078 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award